2021
DOI: 10.1002/advs.202101462
|View full text |Cite
|
Sign up to set email alerts
|

Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure

Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disease with no cure. Huge efforts have been made to develop anti-AD drugs in the past decades. However, all drug development programs for disease-modifying therapies have failed. Possible reasons for the high failure rate include incomplete understanding of complex pathophysiology of AD, especially sporadic AD (sAD), and species difference between humans and animal models used in preclinical studies. In this study, sAD is modeled using human induced … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
49
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 76 publications
(53 citation statements)
references
References 73 publications
1
49
0
Order By: Relevance
“…Although our coculture system with immortalized cell lines is more advanced than monoculture systems, a big gap still exists between each of them and iPSCs-derived models and/or primary human cells, as depicted in Supplementary Figure S3 . Hence, it is essential to validate the neuroprotective potential of regulating miR-124 expression levels in more advanced human personalized AD models, as the three-dimensional spheroids and organoids ( Pomeshchik et al, 2020 ; Chen et al, 2021 ), not forgetting the possibility of new animal models ( Baglietto-Vargas et al, 2021 ; Le Bras, 2021 ). Future studies should also characterize the entire EXO cargo and use miR-124 cellular probing (fluorescent in situ hybridization) to assess its subcellular localization.…”
Section: Discussionmentioning
confidence: 99%
“…Although our coculture system with immortalized cell lines is more advanced than monoculture systems, a big gap still exists between each of them and iPSCs-derived models and/or primary human cells, as depicted in Supplementary Figure S3 . Hence, it is essential to validate the neuroprotective potential of regulating miR-124 expression levels in more advanced human personalized AD models, as the three-dimensional spheroids and organoids ( Pomeshchik et al, 2020 ; Chen et al, 2021 ), not forgetting the possibility of new animal models ( Baglietto-Vargas et al, 2021 ; Le Bras, 2021 ). Future studies should also characterize the entire EXO cargo and use miR-124 cellular probing (fluorescent in situ hybridization) to assess its subcellular localization.…”
Section: Discussionmentioning
confidence: 99%
“…Even if microglial cells were not studied directly in these organoids, an inflammatory response was observed suggesting that this pathological feature could be modeled in such 3D models. Moreover, it was recently shown that exposure of brain models to serum mimics age associated BBB breakdown ( Chen et al, 2021 ), providing a platform to look for effective treatments for disorders with an age component like ALS and FTD.…”
Section: Discussionmentioning
confidence: 99%
“…To date, the technology to generate human embryonic stem cell (hESC)-derived lung cells have changed from traditional two-dimensional (2D) monolayer cell-based differentiation to three-dimensional (3D) organoid differentiation ( Chen et al., 2017 , 2018 ; Dye et al., 2015 ; Kim et al., 2021 ; Li et al., 2021 ). Organoid models possess structural organization similar to the native organ and cell types from multiple germ layers, making them a physiologically complex model to investigate organ developmental processes, drug screening, regeneration and disease modeling in vitro ( Chen et al., 2020 , 2021 ; Clevers, 2016 ; Kim et al., 2021 ; Wang et al., 2021 ). However, current protocols use more cytokines/small molecules and require longer time to generate hESC-derived lung organoids (HLOs) ( Chen et al., 2017 ; Dye et al., 2015 , 2016 ; Strikoudis et al., 2019 ; Wang et al., 2020 ).…”
Section: Before You Beginmentioning
confidence: 99%